Press Releases | Medtronic

Month Year

Email alerts

May 15, 2017

Data Reinforce Benefits of Medtronic Cardiac Resynchronization Therapy Technologies in 'Real-World' Setting

EffectivCRT(TM)and AdaptivCRT(TM) Exclusives Featured in Heart Rhythm 2017 Presentations

DUBLIN - May 15, 2017 - Medtronic plc (NYSE: MDT) today announced new data supporting the clinical performance of the company's exclusive EffectivCRT(TM) Diagnostic and AdaptivCRT(TM) algorithm in...
May 12, 2017

New Study Shows Medtronic Insertable Cardiac Monitors Detect High Rate of Atrial Fibrillation in Previously Undiagnosed High-Risk Patients

Results from the REVEAL AF Study Show That AF Would Have Gone Undetected in the Majority of Patients at High-Risk for AF and Stroke If Cardiac Monitoring Was Limited to 30 Days

DUBLIN and CHICAGO - May 12, 2017 - Medtronic plc (NYSE: MDT) today announced results from a new clinical study showing Medtronic Insertable Cardiac Monitors (ICM) detected a high incidence of...
May 11, 2017

New Medtronic Study Reinforces Safety and Performance of the World's Smallest Pacemaker in a Real-World Patient Population

HRS Late-Breaking Trial Reveals High Implant Success Rate and Low Early Major Complication Rate for the Medtronic Micra® Transcatheter Pacing System (TPS)

DUBLIN and CHICAGO - May 11, 2017 - Medtronic plc (NYSE: MDT) today announced preliminary results for the Medtronic Micra® Transcatheter Pacing System (TPS) Post-Approval Registry, revealing a...
May 10, 2017

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

Portfolio of Next Generation Heart Failure Devices Offers Effective Pacing and Access to the Most Advanced Diagnostic Imaging Procedures

DUBLIN - May 10, 2017 - Medtronic plc (NYSE:MDT) has received U.S. Food and Drug Administration (FDA) approval for a portfolio of quadripolar cardiac resynchronization therapy-pacemakers (CRT-Ps)...
May 9, 2017

Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year 2017

DUBLIN - May 9, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the fourth quarter and fiscal year 2017 on Thursday, May 25, 2017. A news release will be...
May 1, 2017

Medtronic Launches Resolute Onyx™ Drug-Eluting Stent In United States Following FDA Approval Becoming First DES Available In 4.5 mm And 5 mm Sizes

Engineered for Exceptional Deliverability, Advanced DES Technology Features Thinner Struts, Enhanced Visibility and the Broadest Size Matrix in the U.S.

DUBLIN – May 1, 2017 – Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx™ Drug-Eluting Stent (DES). The...
Apr 26, 2017

Five-Year Data from the Medtronic ENGAGE Registry Demonstrate Durable, Consistent, and Proven Outcomes in Real-World Setting

Presented at Charing Cross, Five-Year Clinical Data from Global ENGAGE Registry Support Endurant II's Market-Leading Position Worldwide

DUBLIN and LONDON - April 26, 2017 - Medtronic plc (NYSE:MDT) today reported its Endurant® II abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term durability and...
Apr 25, 2017

Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients

DUBLIN and LONDON - April 25, 2017 - Medtronic plc (NYSE: MDT) today reinforced consistent results for its IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with two new sub-analyses from the...
Apr 25, 2017

New Medtronic Data Demonstrate Clinical and Quality of Life Benefits for VenaSeal Closure System in Venous Reflux Disease Patients

Three-Year VeClose Trial and One-Year WAVES Study Data Presented at Charing Cross

DUBLIN and LONDON - April 25, 2017 - Medtronic plc (NYSE: MDT) today announced three-year outcomes from the VeClose U.S. pivotal clinical trial and one-year data from the WAVES study. Both results...
Apr 24, 2017

Medtronic Announces Most Advanced StealthStation(TM) for Neurosurgery

New Platform to Offer Flexibility, Ease of Use, Improved Registration and Advanced Visualization for Custom Procedural Workflows

DUBLIN and LOS ANGELES - April 24, 2017 - Medtronic plc (NYSE:MDT) today launched its new StealthStation(TM) technology at the American Academy of Neurological Surgeons (AANS) annual conference in...
Apr 20, 2017

Medtronic Brain Therapies Business Sponsors Parkinson's Unity Walk

DUBLIN - April 20, 2017 - Medtronic plc (NYSE: MDT) announced its sponsorship of the 23rdParkinson's Unity Walk which will be held on April 22, 2017, in New York City. Beginning at 8:30 a.m. EDT,...
Apr 20, 2017

Data Highlight Medtronic Vascular Innovations at Charing Cross 2017

New Data from the Global ENGAGE Registry, IN.PACT Admiral Global Study, and VeClose Study Among Key Presentations

LONDON and DUBLIN - April 20, 2017 - Medtronic plc (NYSE: MDT) today announced key clinical studies for its leading vascular interventional portfolio will be featured at the annual 2017 Charing...
Apr 18, 2017

Medtronic Signs Definitive Agreement to Divest a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health for $6.1 Billion

DUBLIN - April 18, 2017 - Medtronic plc (NYSE: MDT) today announced that it has entered into a definitive agreement with Cardinal Health Inc. (NYSE: CAH) to sell its Patient Care, Deep Vein...
Apr 18, 2017

FDA Designates Medtronic Worldwide Voluntary Field Action on HVAD(TM) System Controllers and DC Adapters as Class I Recall

DUBLIN - April 18, 2017 - Medtronic plc (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has classified the company's recently initiated voluntary field action related...
Apr 13, 2017

Medtronic Syncs Garmin® Activity Tracker Data Directly into Remote Patient Monitoring Mobile Platform

Data from Garmin vívofit® Series Now Syncs to Medtronic Care Management Services NetResponse® Mobile Application to Help Track Patient Health at Home

DUBLIN and OLATHE, Kan. - April 13, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, and Garmin International Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), today announced...
Apr 12, 2017

Medtronic Seeks Runners from Around the World Benefitting from Medical Technology for 2017 Global Champions Team

Applications now open: www.medtronic.com/globalchampions

DUBLIN - April 12, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced applications are now open for the 2017 Medtronic Global Champions team. Medtronic...
Apr 6, 2017

Medtronic Announces Voluntary Worldwide Recall of its StrataMR(TM) Adjustable Valves and Shunts

DUBLIN - April 6, 2017 - Medtronic plc (NYSE: MDT) today announced that on February 22, 2017 it notified customers of a voluntary recall of all unused units of the StrataMR(TM) adjustable valves...
Apr 6, 2017

Clinical Trial of Medtronic Heart Pump Delivers Positive Results with Less-Invasive Implant Procedure

HVAD(TM) System is a Mechanical Pump that Circulates Blood Throughout the Body in Patients with Advanced Heart Failure.

DUBLIN and SAN DIEGO - April 6, 2017 - Preliminary results from the Medtronic plc (NYSE:MDT)-sponsored HVAD LATERAL(TM) study were presented today as a late breaking clinical trial during the 2017...
Apr 5, 2017

Medtronic Announces Worldwide Voluntary Field Corrective Action For Newport(TM) HT70 and Newport(TM) HT70 Plus Ventilators

DUBLIN - April 5, 2017 - Medtronic (NYSE: MDT) is notifying customers worldwide of a voluntary field corrective action for all its Newport HT70 and Newport HT70 Plus ventilators manufactured since...
Apr 5, 2017

Study Shows Medtronic Left Ventricular Assist Devices Have Positive Results at One Year in Patients Seeking Long-Term LVAD Therapy

GLOBE NEWSWIRE via COMTEX) --Data Presented in Late-Breaking Presentation at ISHLT 2017 DUBLIN and SAN DIEGO - April 5, 2017 - Medtronic plc (NYSE:MDT) today announced results of the ENDURANCE...
Mar 30, 2017

Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation

DUBLIN - March 30, 2017 - Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP Persistent AF clinical trial. The trial will evaluate the safety and effectiveness of a pulmonary...
Mar 24, 2017

New Guidelines Support Use of Cardiac Monitoring for Patients with Unexplained Fainting

American College of Cardiology, American Heart Association and Heart Rhythm Society Jointly Issue First-Ever Syncope Guidelines that Reinforce Benefits of Continuous Cardiac Monitoring

DUBLIN - March 24, 2017 - Newly published guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) recommend the use of...
Mar 21, 2017

Medtronic Announces Pricing of $2 Billion of Senior Notes

GLOBE NEWSWIRE via COMTEX) --DUBLIN - March 21, 2017 - Medtronic plc (NYSE: MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), has priced...
Mar 21, 2017

Medtronic Receives FDA Approval for CoreValve(TM) Evolut(TM) Pro Transcatheter Valve with Advanced Sealing

First-Ever Data at ACC.17 Confirms Safety and Efficacy of New Self-Expanding, Recapturable Heart Valve at 30-Days with High Survival, Low Stroke and Minimal Paravalvular Leak

DUBLIN - March 22, 2017 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve(TM) Evolut(TM) PRO valve for the treatment of...
Mar 17, 2017

Landmark SURTAVI Clinical Trial Shows Transcatheter Aortic Valve Replacement (TAVR) with the Self-Expanding Platform Performs as Well as Surgery in Intermediate Risk Severe Aortic Stenosis Patients

Late-Breaking SURTAVI Pivotal Clinical Trial Presented at ACC.17 and Published in NEJM Meets Primary Endpoint at Two Years

DUBLIN and WASHINGTON, D.C. - March 17, 2017 - Medtronic plc (NYSE: MDT) today unveiled first-ever clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)...

Show per page